Perioperative systemic chemo-immunotherapy for upper urinary tract urothelial carcinoma

Eu Chang Hwang, Niranjan J. Sathianathen, Jae Hung Jung, Myung Ha Kim, Vikram Narayan, Jun Eul Hwang, Philippe E. Spiess, Philipp Dahm

Research output: Contribution to journalArticlepeer-review

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:. To assess the effects of perioperative systemic chemotherapy or immunotherapy (or both) for UTUC.

Original languageEnglish
Article numberCD013567
JournalCochrane Database of Systematic Reviews
Volume2020
Issue number3
DOIs
Publication statusPublished - 2020 Mar 30

Bibliographical note

Funding Information:
We are very grateful to Dr Sumit Isharwal (Department of Urology, University of Virginia) and Dr Amishi Y Shah (Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center) for assistance in the preparation of this protocol. We thank Cochrane Urology and our contact editor Andrew Shepherd for supporting this protocol.

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Perioperative systemic chemo-immunotherapy for upper urinary tract urothelial carcinoma'. Together they form a unique fingerprint.

Cite this